SCHEMBL1082875

SCHEMBL1082875

CCC(N)CC(CO)(CO)S(=O)(=O)O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1769484 0.81 TP53 (0.32) TP53
SCHEMBL6766679 0.71
Sulfuric Acid SCHEMBL5883810 0.70 TP53 (0.46) TP53
Trifluoromethanesulfonic Acid SCHEMBL609217 0.70 TP53 (0.34) TP53
SCHEMBL28982366 0.69 CA5A (0.33)
Sulfuric Acid SCHEMBL29043937 0.69 TP53 (0.41) TP53
Sulfuric Acid SCHEMBL29043936 0.69 TP53 (0.41) TP53
Sulfuric Acid SCHEMBL5429506 0.69 TP53 (0.41) TP53
Ammonia Solution, Strong SCHEMBL28609100 0.69
SCHEMBL8662505 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494396-A1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF Pierce Biotechnology, Inc. (US) 2019-06-12 EP claimed
WO-2018027004-A1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF PIERCE BIOTECHNOLOGY, INC. (US) 2018-02-08 WO claimed
EP-2580201-A2 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF Rhodes Technologies (US) 2013-04-17 EP claimed
EP-2449374-A1 SENSOR FILMS, METHODS FOR MAKING AND METHODS FOR MONITORING WATER-SOLUBLE POLYMER CONCENTRATIONS General Electric Company (US) 2012-05-09 EP claimed
WO-2011154827-A2 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF RHODES TECHNOLOGIES (US) 2011-12-15 WO claimed
WO-2011002642-A1 SENSOR FILMS, METHODS FOR MAKING AND METHODS FOR MONITORING WATER-SOLUBLE POLYMER CONCENTRATIONS GENERAL ELECTRIC COMPANY (US) 2011-01-06 WO claimed
EP-1853696-A2 ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS, AND METHODS FOR THEIR USE INVITROGEN CORPORATION (US) 2007-11-14 EP claimed
WO-2006091525-A2 ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS, AND METHODS FOR THEIR USE INVITROGEN CORPORATION (US) 2006-08-31 WO claimed
EP-4142740-A1 COMPOSITIONS AND METHODS OF USE THEREOF Synedgen, Inc. (US) 2023-03-08 EP disclosed
WO-2022216781-A1 METHODS AND SYSTEMS FOR CRYSTALLIZING AND ISOLATING INDIVIDUAL CANNABINOIDS MYKU Biosciences LLC (US) 2022-10-13 WO disclosed
EP-4013865-A1 PROCESSES FOR PURIFYING DOWNSTREAM PRODUCTS OF IN VITRO TRANSCRIPTION ModernaTX, Inc. (US) 2022-06-22 EP disclosed
WO-2021221656-A1 COMPOSITIONS AND METHODS OF USE THEREOF SYNEDGEN, INC. (US) 2021-11-04 WO disclosed
WO-2021195150-A1 DEVICES AND METHODS FOR DETECTION OF TARGET VIRUSES VISBY MEDICAL, INC. (US) 2021-09-30 WO disclosed
WO-2021030533-A1 PROCESSES FOR PURIFYING DOWNSTREAM PRODUCTS OF IN VITRO TRANSCRIPTION MODERNATX, INC. (US) 2021-02-18 WO disclosed
WO-2008101024-A2 LABELING AND DETECTION OF NUCLEIC ACIDS INVITROGEN CORPORATION (US) 2008-08-21 WO disclosed
WO-2008029281-A2 LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS INVITROGEN CORPORATION (US) 2008-03-13 WO disclosed
WO-2008028127-A1 METHODS, CASSETTES, GELS AND APPARATUSES FOR ISOLATION AND COLLECTION OF BIOMOLECULES FROM ELECTROPHORESIS GELS Life Technologies Corporation (US) 2008-03-06 WO disclosed
EP-1853696-A2 ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS, AND METHODS FOR THEIR USE INVITROGEN CORPORATION (US) 2007-11-14 EP disclosed
WO-2007076452-A1 COMPOSITIONS AND METHODS FOR IMPROVING RESOLUTION OF BIOMOLECULES SEPARATED ON POLYACRYLAMIDE GELS INVITROGEN CORPORATION (US) 2007-07-05 WO disclosed
WO-2006091525-A2 ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS, AND METHODS FOR THEIR USE INVITROGEN CORPORATION (US) 2006-08-31 WO disclosed